Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Herling, M; Rassidakis, GZ; Viviani, S; Bonfante, V; Giardini, R; Gianni, M; Morris, SW; Cabanillas, F; Medeiros, LJ; Sarris, AH
   Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: Results with ALK-11 antibody in 327 untreated patients
   LEUKEMIA & LYMPHOMA
   
   M. Herling et al., "Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: Results with ALK-11 antibody in 327 untreated patients", LEUK LYMPH, 42(5), 2001, pp. 969
2. Al-Hashmi, I; Decoteau, J; Gruss, HJ; Zielenska, M; Thorner, P; Poon, A; Reis, M; Freedman, M; Lorenzana, A
   Establishment of a cytokine-producing anaplastic large-cell lymphoma cell line containing the t(2;5) translocation: Potential role of cytokines in clinical manifestations
   LEUKEMIA & LYMPHOMA
   
   I. Al-Hashmi et al., "Establishment of a cytokine-producing anaplastic large-cell lymphoma cell line containing the t(2;5) translocation: Potential role of cytokines in clinical manifestations", LEUK LYMPH, 40(5-6), 2001, pp. 599-611
3. Coffin, CM; Patel, A; Perkins, S; Elenitoba-Johnson, KSJ; Perlman, E; Griffin, CA
   ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor
   MODERN PATHOLOGY
   
   C.M. Coffin et al., "ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor", MOD PATHOL, 14(6), 2001, pp. 569-576
4. Yao, JL; Cangiarella, JF; Cohen, JM; Chhieng, DC
   Fine-needle aspiration biopsy of peripheral T-cell lymphomas - A cytologicand immunophenotypic study of 33 cases
   CANCER CYTOPATHOLOGY
   
   J.L. Yao et al., "Fine-needle aspiration biopsy of peripheral T-cell lymphomas - A cytologicand immunophenotypic study of 33 cases", CANC CYTOP, 93(2), 2001, pp. 151-159
5. Falini, B
   Anaplastic large cell lymphoma: Pathological, molecular and clinical features
   BRITISH JOURNAL OF HAEMATOLOGY
   
   B. Falini, "Anaplastic large cell lymphoma: Pathological, molecular and clinical features", BR J HAEM, 114(4), 2001, pp. 741-760
6. Morris, SW; Xue, LQ; Ma, ZG; Kinney, MC
   ALK(+) CD30(+) lymphomas: A distinct molecular genetic subtype of non-Hodgkin's lymphoma
   BRITISH JOURNAL OF HAEMATOLOGY
   
   S.W. Morris et al., "ALK(+) CD30(+) lymphomas: A distinct molecular genetic subtype of non-Hodgkin's lymphoma", BR J HAEM, 113(2), 2001, pp. 275-295
7. Camilleri-Broet, S; Audouin, J; Ferme, C; Briere, J; Pulford, K; Gaulard, P; Divine, M; Macintyre, E; Delsol, G; Berger, F
   ALK is not expressed in Hodgkin disease
   BLOOD
   
   S. Camilleri-Broet et al., "ALK is not expressed in Hodgkin disease", BLOOD, 97(6), 2001, pp. 1901-1902
8. Maes, B; Vanhentenrijk, V; Wlodarska, I; Cools, J; Peeters, B; Marynen, P; De Wolf-Peeters, C
   The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells
   AMERICAN JOURNAL OF PATHOLOGY
   
   B. Maes et al., "The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells", AM J PATH, 158(6), 2001, pp. 2185-2193
9. Drexler, HG; Gignac, SM; von Wasielewski, R; Werner, M; Dirks, WG
   Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
   LEUKEMIA
   
   H.G. Drexler et al., "Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas", LEUKEMIA, 14(9), 2000, pp. 1533-1559
10. Haralambieva, E; Pulford, KAF; Lamant, L; Pileri, S; Roncador, G; Gatter, KC; Delsol, G; Mason, DY
    Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas
    BRITISH JOURNAL OF HAEMATOLOGY
    
    E. Haralambieva et al., "Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas", BR J HAEM, 109(3), 2000, pp. 584-591
11. Touriol, C; Greenland, C; Lamant, L; Pulford, K; Bernard, F; Rousset, T; Mason, DY; Delsol, G
    Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)
    BLOOD
    
    C. Touriol et al., "Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)", BLOOD, 95(10), 2000, pp. 3204-3207
12. Moccia, F; Tognoni, E; Boccaccio, P
    ALK-negative anaplastic large cell lymphoma and Hodgkin's disease of nodular sclerosing type in 2 siblings
    ACTA HAEMATOLOGICA
    
    F. Moccia et al., "ALK-negative anaplastic large cell lymphoma and Hodgkin's disease of nodular sclerosing type in 2 siblings", ACT HAEMAT, 103(4), 2000, pp. 214-219
13. Felgar, RE; Salhany, KE; Macon, WR; Pietra, GG; Kinney, MC
    The expression of TIA-1(+) cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30(+) anaplastic large cell lymphomas (ALCL): Correlation with morphology, immunophenotype, ultrastructure, and clinical features
    HUMAN PATHOLOGY
    
    R.E. Felgar et al., "The expression of TIA-1(+) cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30(+) anaplastic large cell lymphomas (ALCL): Correlation with morphology, immunophenotype, ultrastructure, and clinical features", HUMAN PATH, 30(2), 1999, pp. 228-236
14. Mori, N; Watanabe, K; Yamashita, Y; Nakayama, A; Yatabe, Y; Narita, M; Kobayashi, T; Hasegawa, Y; Kojima, H; Nagasawa, T
    Hodgkin disease with subsequent transformation to CD30 positive non-Hodgkin lymphoma in six patients
    CANCER
    
    N. Mori et al., "Hodgkin disease with subsequent transformation to CD30 positive non-Hodgkin lymphoma in six patients", CANCER, 85(4), 1999, pp. 970-979
15. Bayle, C; Charpentier, A; Duchayne, E; Manel, AM; Pages, MP; Robert, A; Lamant, L; Dastugue, N; Bertrand, Y; Dijoud, F; Emile, JF; Machover, D; Brugieres, L; Delsol, G
    Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases
    BRITISH JOURNAL OF HAEMATOLOGY
    
    C. Bayle et al., "Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases", BR J HAEM, 104(4), 1999, pp. 680-688
16. Lamant, L; Dastugue, N; Pulford, K; Delsol, G; Mariame, B
    A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation
    BLOOD
    
    L. Lamant et al., "A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation", BLOOD, 93(9), 1999, pp. 3088-3095
17. Kinney, MC; Kadin, ME
    The pathologic and clinical spectrum of anaplastic large cell lymphoma andcorrelation with ALK gene dysregulation
    AJCP. American journal of clinical pathology
    
    M.C. Kinney e M.E. Kadin, "The pathologic and clinical spectrum of anaplastic large cell lymphoma andcorrelation with ALK gene dysregulation", AM J CLIN P, 111(1), 1999, pp. S56-S67
18. KADIN ME; MORRIS SW
    THE T(2-5) IN HUMAN LYMPHOMAS
    Leukemia & lymphoma
    
    M.E. Kadin e S.W. Morris, "THE T(2-5) IN HUMAN LYMPHOMAS", Leukemia & lymphoma, 29(3-4), 1998, pp. 249
19. GARY GS
    ANALYSIS OF THE T(2-5) (P23-Q35) TRANSLOCATION IN CD30(-DISEASE() PRIMARY CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS AND HODGKINS)
    Leukemia & lymphoma
    
    G.S. Gary, "ANALYSIS OF THE T(2-5) (P23-Q35) TRANSLOCATION IN CD30(-DISEASE() PRIMARY CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS AND HODGKINS)", Leukemia & lymphoma, 29(1-2), 1998, pp. 93-101
20. LOPEZGUILLERMO A; CID J; SALAR A; LOPEZ A; MONTALBAN C; CASTRILLO JM; GONZALEZ M; RIBERA JM; BRUNET S; GARCIACONDE J; DESEVILLA AF; BOSCH F; MONTSERRAT E
    PERIPHERAL T-CELL LYMPHOMAS - INITIAL FEATURES, NATURAL-HISTORY, AND PROGNOSTIC FACTORS IN A SERIES OF 174 PATIENTS DIAGNOSED ACCORDING TO THE REAL CLASSIFICATION
    Annals of oncology
    
    A. Lopezguillermo et al., "PERIPHERAL T-CELL LYMPHOMAS - INITIAL FEATURES, NATURAL-HISTORY, AND PROGNOSTIC FACTORS IN A SERIES OF 174 PATIENTS DIAGNOSED ACCORDING TO THE REAL CLASSIFICATION", Annals of oncology, 9(8), 1998, pp. 849-855
21. VERGIER B; BEYLOTBARRY M; PULFORD K; MICHEL P; BOSQ J; DEMURET A; BEYLOT C; DELAUNAY MM; AVRIL MF; DALAC S; BODEMER C; JOLY P; GROPPI A; DEMASCAREL A; BAGOT M; MASON DY; WECHSLER J; MERLIO JP
    STATISTICAL EVALUATION OF DIAGNOSTIC AND PROGNOSTIC FEATURES OF CD30-A CLINICOPATHOLOGICAL STUDY OF 65 CASES( CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS )
    The American journal of surgical pathology
    
    B. Vergier et al., "STATISTICAL EVALUATION OF DIAGNOSTIC AND PROGNOSTIC FEATURES OF CD30-A CLINICOPATHOLOGICAL STUDY OF 65 CASES( CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS )", The American journal of surgical pathology, 22(10), 1998, pp. 1192-1202
22. MASON DY; PULFORD KAF; BISCHOF D; KUEFER MU; BUTLER LH; LAMANT L; DELSOL G; MORRIS SW
    NUCLEOLAR LOCALIZATION OF THE NUCLEOPHOSMIN ANAPLASTIC LYMPHOMA KINASE IS NOT REQUIRED FOR MALIGNANT TRANSFORMATION
    Cancer research
    
    D.Y. Mason et al., "NUCLEOLAR LOCALIZATION OF THE NUCLEOPHOSMIN ANAPLASTIC LYMPHOMA KINASE IS NOT REQUIRED FOR MALIGNANT TRANSFORMATION", Cancer research, 58(5), 1998, pp. 1057-1062
23. Trumper, L; Pfreundschuh, M; Bonin, FV; Daus, H
    Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral bloodcells of healthy individuals
    BRITISH JOURNAL OF HAEMATOLOGY
    
    L. Trumper et al., "Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral bloodcells of healthy individuals", BR J HAEM, 103(4), 1998, pp. 1138-1144
24. BRUGIERES L; LEDELEY MC; PACQUEMENT H; MEGUERIANBEDOYAN Z; TERRIERLACOMBE MJ; ROBERT A; PONDARRE C; LEVERGER G; DEVALCK C; RODARY C; DELSOL G; HARTMANN O
    CD30(-CELL LYMPHOMA IN CHILDREN - ANALYSIS OF 82 PATIENTS ENROLLED IN2 CONSECUTIVE STUDIES OF THE FRENCH-SOCIETY-OF-PEDIATRIC-ONCOLOGY() ANAPLASTIC LARGE)
    Blood
    
    L. Brugieres et al., "CD30(-CELL LYMPHOMA IN CHILDREN - ANALYSIS OF 82 PATIENTS ENROLLED IN2 CONSECUTIVE STUDIES OF THE FRENCH-SOCIETY-OF-PEDIATRIC-ONCOLOGY() ANAPLASTIC LARGE)", Blood, 92(10), 1998, pp. 3591-3598
25. BENHARROCH D; MEGUERIANBEDOYAN Z; LAMANT L; AMIN C; BRUGIERES L; TERRIERLACOMBE MJ; HARALAMBIEVA E; PULFORD K; PILERI S; MORRIS SW; MASON DY; DELSOL G
    ALK-POSITIVE LYMPHOMA - A SINGLE DISEASE WITH A BROAD-SPECTRUM OF MORPHOLOGY
    Blood
    
    D. Benharroch et al., "ALK-POSITIVE LYMPHOMA - A SINGLE DISEASE WITH A BROAD-SPECTRUM OF MORPHOLOGY", Blood, 91(6), 1998, pp. 2076-2084
26. BEYLOTBARRY M; GROPPI A; VERGIER B; PULFORD K; MERLIO JP
    CHARACTERIZATION OF T(2-5) RECIPROCAL TRANSCRIPTS AND GENOMIC BREAKPOINTS IN CD30(+) CUTANEOUS LYMPHOPROLIFERATIONS
    Blood
    
    M. Beylotbarry et al., "CHARACTERIZATION OF T(2-5) RECIPROCAL TRANSCRIPTS AND GENOMIC BREAKPOINTS IN CD30(+) CUTANEOUS LYMPHOPROLIFERATIONS", Blood, 91(12), 1998, pp. 4668-4676
27. FALINI B; BIGERNA B; FIZZOTTI M; PULFORD K; PILERI SA; DELSOL G; CARBONE A; PAULLI M; MAGRINI U; MENESTRINA F; GIARDINI R; PILOTTI S; MEZZELANI A; UGOLINI B; BILLI M; PUCCIARINI A; PACINI R; PELICCI PG; FLENGHI L
    ALK EXPRESSION DEFINES A DISTINCT GROUP OF T NULL LYMPHOMAS (ALK LYMPHOMAS) WITH A WIDE MORPHOLOGICAL SPECTRUM/
    The American journal of pathology
    
    B. Falini et al., "ALK EXPRESSION DEFINES A DISTINCT GROUP OF T NULL LYMPHOMAS (ALK LYMPHOMAS) WITH A WIDE MORPHOLOGICAL SPECTRUM/", The American journal of pathology, 153(3), 1998, pp. 875-886
28. SU LD; SCHNITZER B; ROSS CW; VASEF M; MORI S; SHIOTA M; MASON DY; PULFORD K; HEADINGTON JT; SINGLETON TP
    THE T(2-5)-ASSOCIATED P80 NPM ALK FUSION PROTEIN IN NODAL AND CUTANEOUS CD30+ LYMPHOPROLIFERATIVE DISORDERS/
    Journal of cutaneous pathology
    
    L.D. Su et al., "THE T(2-5)-ASSOCIATED P80 NPM ALK FUSION PROTEIN IN NODAL AND CUTANEOUS CD30+ LYMPHOPROLIFERATIVE DISORDERS/", Journal of cutaneous pathology, 24(10), 1997, pp. 597-603
29. LADANYI M
    THE NPM ALK GENE FUSION IN THE PATHOGENESIS OF ANAPLASTIC LARGE-CELL LYMPHOMA/
    Cancer surveys
    
    M. Ladanyi, "THE NPM ALK GENE FUSION IN THE PATHOGENESIS OF ANAPLASTIC LARGE-CELL LYMPHOMA/", Cancer surveys, 30, 1997, pp. 59-75
30. CHITTAL SM; DELSOL G
    THE INTERFACE OF HODGKINS-DISEASE AND ANAPLASTIC LARGE-CELL LYMPHOMA
    Cancer surveys
    
    S.M. Chittal e G. Delsol, "THE INTERFACE OF HODGKINS-DISEASE AND ANAPLASTIC LARGE-CELL LYMPHOMA", Cancer surveys, 30, 1997, pp. 87-105
31. NAKAMURA S; SHIOTA M; NAKAGAWA A; YATABE Y; KOJIMA M; MOTOORI T; SUZUKI R; KAGAMI Y; OGURA M; MORISHIMA Y; MIZOGUCHI Y; OKAMOTO M; SETO M; KOSHIKAWA T; MORI S; SUCHI T
    ANAPLASTIC LARGE-CELL LYMPHOMA - A DISTINCT MOLECULAR PATHOLOGICAL ENTITY - A REAPPRAISAL WITH SPECIAL REFERENCE TO P80(NPM ALK) EXPRESSION/
    The American journal of surgical pathology
    
    S. Nakamura et al., "ANAPLASTIC LARGE-CELL LYMPHOMA - A DISTINCT MOLECULAR PATHOLOGICAL ENTITY - A REAPPRAISAL WITH SPECIAL REFERENCE TO P80(NPM ALK) EXPRESSION/", The American journal of surgical pathology, 21(12), 1997, pp. 1420-1432
32. HERBST H; SANDER C; TRONNIER M; KUTZNER H; HUGEL H; KAUDEWITZ P
    ABSENCE OF ANAPLASTIC LYMPHOMA KINASE (ALK) AND EPSTEIN-BARR-VIRUS GENE-PRODUCTS IN PRIMARY CUTANEOUS ANAPLASTIC LARGE-CELL LYMPHOMA AND LYMPHOMATOID PAPULOSIS
    British journal of dermatology
    
    H. Herbst et al., "ABSENCE OF ANAPLASTIC LYMPHOMA KINASE (ALK) AND EPSTEIN-BARR-VIRUS GENE-PRODUCTS IN PRIMARY CUTANEOUS ANAPLASTIC LARGE-CELL LYMPHOMA AND LYMPHOMATOID PAPULOSIS", British journal of dermatology, 137(5), 1997, pp. 680-686